Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-05 Nolan Sean P. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2019-10-10 Nolan Sean P. Director Grant or award · Stock Option (right to buy) +22,000 22,000
2018-05-07 Nolan Sean P. Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2017-05-08 Nolan Sean P. Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2016-05-09 Nolan Sean P. Director Grant or award · Stock Option (Right to Buy) +7,500 7,500

Page 1 of 1 · 5 trades